The best tweets were selected from influencers tracked by GlobalData’s Influencer Platform, based on a scientific process that works on predefined parameters. Influencers are selected after an in-depth analysis of the leading discussions regarding influencer relevance, network strength, engagement, and new and emerging trends.
Most popular tweets about infectious diseases in the second quarter of 2021: Top five
1. Laurie Garret’s tweet about Covid-19 survivors suffering from neurological or mental health problems
Laurie Garret, a science journalist and author, shared an article about a cohort study and analysis of data from electronic health records of 236,379 Covid-19 victims provided by TriNetX, a health research network. The analysis aimed to determine the incidence rate and risk of neurological and psychiatric diagnoses such as intracranial hemorrhage, Guillain-Barré syndrome, encephalitis, dementia and anxiety disorders in survivors of Covid-19 six months after contracting the infection.
The analysis showed that the incidence of such diagnoses in patients was 33.62%, with 12.84% of patients being diagnosed for the first time. Also, patients with severe Covid-19 were at higher risk of developing neurological and psychiatric conditions. The study was funded by the Oxford Health Biomedical Research Center of the National Institute for Health Research (NIHR), a partnership between the Oxford Health NHS Foundation Trust and the University of Oxford.
— Laurie Garrett (@Laurie_Garrett) April 6, 2021
Username: Laurie Garrett
Twitter handle: @Laurie_Garrett
2. Francis S. Collins tweet about the production of human antibodies targeting the spike protein of the coronavirus
Francis S. Collins, director of the National Institutes of Health (NIH), shared an article on an institute-funded study on how a mild Covid-19 infection can produce antibodies that target various areas of the coronavirus spike protein. Previous studies have focused on antibodies that target a specific part of the spike protein called the receptor binding domain (RBD), which binds directly to human cells.
The new study, led by researchers from the University of Texas, took an alternative approach, examining the entire range of antibodies produced against the spike protein of the coronavirus from four people who have recently recovered from coronavirus infection. The study’s findings showed that a strong immune response to the coronavirus’s spike protein did not concentrate only on the RBD, but instead targeted all areas of the spike protein. The research is expected to help develop targeted therapies and save the lives of patients with severe Covid infections.
A new study finds success #immunity reaction #COVID-19 includes #antibodies hitting multiple parts #Virgo, not just RBD. This #simple Research It could point to new ways to treat or prevent COVID19. #NIH https://t.co/Ctuc9YfHR9
— Francis S. Collins (@NIHDrector) May 18, 2021
Username: Francis S. Collins
Twitter handle: @NIHDdirector
3. Carlos del Rio’s tweet on the effectiveness of Pfizer and BioNTech’s Covid-19 vaccine
Carlos del Rio, executive vice dean at Emory University School of Medicine, shared an article on the effectiveness of Pfizer and BioNTech’s mRNA vaccine, BNT162b2. The two-dose vaccine is the first Covid-19 vaccine to be granted an Emergency Use Authorization (EUA) for older adolescents and adults by the US Food and Drug Administration (FDA).
New data from an ongoing phase III study in confirmed symptomatic Covid-19 cases showed that six months after receiving the second dose, the vaccine was 91.3% effective against Covid-19. The data also confirm the safety and efficacy of the vaccine against variants crucial to achieving herd immunity. Pfizer and BioNTech are expected to submit a Biological License Application (BLA) for the vaccine based on six months of data.
– Carlos del Rio (@ CarlosdelRio7) April 2, 2021
Username: Carlos del Rio
Twitter handle: @ CarlosdelRio7
4. Dr. Maimuna Majumder’s tweet about increasing Covid-19 cases in India
Harvard Medical School faculty member Dr. Maimuna Majumder shared an article about the increasing Covid-19 cases in India. The second wave of the coronavirus pandemic in the country has caused a rapid increase in coronavirus cases. The increase in cases also introduced the risk of introducing new variants that could not be traced without effective genomic sequencing.
The article adds that India is currently lagging behind other countries in genomic sequencing, which could lead to variants spreading to other countries without being detected. The situation can be challenging for local and global health officials when tracking variants. Scientists have yet to trace the origins of some variants discovered in the UK, Africa and Brazil.
India’s current #COVID-19 surge (and the opportunity it offers for new opportunities) #SARS COV-2 variants that will emerge) are a stark reminder that none of us is safe until we all are: https://t.co/xzKTHq8M7o
– Dr. Maimuna Majumder (@maiamajumder) April 17, 2021
Username: Dr. Maimuna Majumder
Twitter handle: @maiamajumder
5. Dr. Saskia Popescu’s tweet about the decline in Kovid-19 cases in US states with high vaccination rates
An assistant professor in the George Mason University Biodefense Program, Dr. Saskia Popescu shared an article on how the cases of Covid-19 decreased in the states where residents were vaccinated, and the cases increased in places where vaccination rates were low. States with low vaccination rates also report higher hospitalization rates.
Experts think that the number of cases will continue to rise, as easily transmitted variants can spread faster in areas with a high concentration of unvaccinated people who stop following social distance and mask-wearing measures. For example, the delta variant was reported in 6% of new infections in the USA. Increasing vaccinations could help reduce the rising number of cases, but people’s reluctance to get vaccinated remains a challenge, the paper says.
Coronavirus infections fall where people are vaccinated, rise where they aren’t, Post analysis finds https://t.co/LCn27WkYIz
– Dr. Saskia Popescu (@SaskiaPopescu) 14 June 2021
Username: Dr. Saskia Popescu
Twitter handle: @SaskiaPopescu